XMLH.DE vs. ETLI.DE
XMLH.DE (L&G Healthcare Technology & Innovation UCITS ETF USD Acc) and ETLI.DE (L&G Pharma Breakthrough UCITS ETF) are both Health & Biotech Equities funds - XMLH.DE tracks the ROBO Global Healthcare Technology and Innovation Index while ETLI.DE tracks the Solactive Pharma Breakthrough Value. Both are passively managed. Over the past 5 years, XMLH.DE returned -2.65%/yr vs 3.39%/yr for ETLI.DE. A 0.68 correlation means they provide meaningful diversification when combined. Both charge a 0.49% expense ratio.
Performance
XMLH.DE vs. ETLI.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XMLH.DE achieves a 8.53% return, which is significantly lower than ETLI.DE's 9.93% return.
XMLH.DE
- 1D
- -0.63%
- 1M
- 9.04%
- 6M
- 3.67%
- YTD
- 8.53%
- 1Y
- 37.82%
- 3Y*
- 7.32%
- 5Y*
- -2.65%
- 10Y*
- —
ETLI.DE
- 1D
- -0.62%
- 1M
- 9.09%
- 6M
- 9.09%
- YTD
- 9.93%
- 1Y
- 36.02%
- 3Y*
- 10.10%
- 5Y*
- 3.39%
- 10Y*
- —
XMLH.DE vs. ETLI.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XMLH.DE L&G Healthcare Technology & Innovation UCITS ETF USD Acc | 8.53% | 11.69% | 8.01% | -4.50% | -29.19% | 7.76% | 49.95% | -0.52% |
ETLI.DE L&G Pharma Breakthrough UCITS ETF | 9.93% | 22.18% | 0.42% | -12.66% | -2.85% | 4.96% | 15.32% | 7.92% |
Correlation
The correlation between XMLH.DE and ETLI.DE is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.62 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.66 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2019 | 0.68 |
The correlation between XMLH.DE and ETLI.DE has been stable across timeframes, ranging from 0.60 to 0.68 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XMLH.DE vs. ETLI.DE — Risk / Return Rank
XMLH.DE
ETLI.DE
XMLH.DE vs. ETLI.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) and L&G Pharma Breakthrough UCITS ETF (ETLI.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XMLH.DE | ETLI.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.11 | ||
| Sortino ratioReturn per unit of downside risk | +0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.30 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 2.64 | 3.97 | -1.33 |
| Martin ratioReturn relative to average drawdown | 5.92 | 11.65 | -5.73 |
Loading charts...
Drawdowns
XMLH.DE vs. ETLI.DE - Drawdown Comparison
The maximum XMLH.DE drawdown since its inception was -51.48%, which is greater than ETLI.DE's maximum drawdown of -30.84%. Use the drawdown chart below to compare losses from any high point for XMLH.DE and ETLI.DE.
Loading charts...
Drawdown Indicators
| XMLH.DE | ETLI.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.48% | -30.84% | -20.64% |
Max Drawdown (1Y)Largest decline over 1 year | -15.46% | -9.04% | -6.42% |
Max Drawdown (3Y)Largest decline over 3 years | -28.40% | -23.14% | -5.26% |
Max Drawdown (5Y)Largest decline over 5 years | -50.58% | -30.84% | -19.74% |
Current DrawdownCurrent decline from peak | -21.16% | -6.00% | -15.16% |
Average DrawdownAverage peak-to-trough decline | -25.17% | -9.98% | -15.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.91% | 3.08% | +3.83% |
Volatility
XMLH.DE vs. ETLI.DE - Volatility Comparison
L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) has a higher volatility of 6.98% compared to L&G Pharma Breakthrough UCITS ETF (ETLI.DE) at 6.09%. This indicates that XMLH.DE's price experiences larger fluctuations and is considered to be riskier than ETLI.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XMLH.DE | ETLI.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.98% | 6.09% | +0.89% |
Volatility (6M)Calculated over the trailing 6-month period | 16.00% | 14.32% | +1.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.03% | 19.45% | +1.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.53% | 17.42% | +5.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.79% | 18.72% | +5.07% |
XMLH.DE vs. ETLI.DE - Expense Ratio Comparison
Both XMLH.DE and ETLI.DE have an expense ratio of 0.49%.
Dividends
XMLH.DE vs. ETLI.DE - Dividend Comparison
Neither XMLH.DE nor ETLI.DE has paid dividends to shareholders.
Frequently Asked Questions
XMLH.DE and ETLI.DE have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.49% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
XMLH.DE and ETLI.DE have the same expense ratio: 0.49% per year.
XMLH.DE tracks ROBO Global Healthcare Technology and Innovation Index, while ETLI.DE tracks Solactive Pharma Breakthrough Value. They also come from different issuers: L&G and Legal & General.
Find the right allocation for XMLH.DE and ETLI.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer